Gaorong Ventures

Activity from announced rounds

All recorded activity

Gaorong Ventures, also identified as Gaorong Capital, is the investment organization connected to Axoft and Moonwalk financing histories.

Recorded funding activity

Moonwalk develops medicines targeting fat-tissue pathways, while Axoft develops implanted brain-computer interfaces. The recorded activity also includes Anew’s combination of molecular models and experimental biology for drug discovery. These companies pursue different clinical technologies.

Sources
Rounds participated in
11
Confirmed lead rounds
2
2 roles undisclosed
New companies
9
First participation on record · 2 follow-on
Funding in participating rounds
$1.6B
7 disclosed · full round size, not this investor’s share

By stage

Seed3
Undisclosed3
Series A2
Series B2
Series C+1

By primary sector

Biotech5
Healthtech4
AI1
Robotics1

By country

China8
United States2
Cayman Islands1

Rounds

11 in all activity
Active Intelligence Technologies

Active Intelligence Technologies develops implantable brain-computer interfaces to help patients regain communication, movement and sensory function.

CN¥464MAngel+
Lead
Nanochap

Develops retinal and cortical brain-computer interfaces that use electrical stimulation to create artificial visual perception.

CN¥500MSeries C+
Lead
Anew Labs

An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.

$290MFunding
Participant
Moonwalk Biosciences

Moonwalk Biosciences is developing adipose-targeted siRNA medicines for obesity and cardiometabolic disease. Its lead programs are designed to alter fat-tissue pathways while limiting effects on other tissues, with the lead obesity candidate in IND-enabling development ahead of planned human testing in 2027.

$70MSeries B
Participant
Dogotix Inc. (XPeng Robotics)

Dogotix Inc. is the holding company for XPeng’s robotics business, which develops humanoid and other general-purpose robotic systems.

$900MConditional Series A subscription agreements
Participant
Evoken

Evoken builds AI tools for image, design and video production.

~$300MSeries B+
Participant
BioGeometry

BioGeometry develops generative AI models and experimental workflows for protein design, drug discovery and enzyme engineering.

UndisclosedStrategic financing
Participant
Axoft

Develops implantable Brain-Computer Interfaces (iBCIs) for neurological disorders

$55MSeries A
Role not disclosed
Pulnovo Medical

Develops interventional therapies for pulmonary hypertension and heart failure

$100MStrategic
Role not disclosed
BioGeometry

BioGeometry develops generative AI models and experimental workflows for protein design, drug discovery and enzyme engineering.

Participant
BioGeometry

BioGeometry develops generative AI models and experimental workflows for protein design, drug discovery and enzyme engineering.

UndisclosedAngel round
Participant